Study on tropomyosin, a common and major allergen in Crustacea

甲壳类常见且主要过敏原原肌球蛋白的研究

基本信息

  • 批准号:
    13680157
  • 负责人:
  • 金额:
    $ 1.92万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2002
  • 项目状态:
    已结题

项目摘要

Recently, in Japan, many patients are suffering from allergy eliciting by ingestion of shrimp. Shrimp is an important foodstuff of the animal protein in view of its consumption quantity in this country. In order to elucidate the allergenicity of shrimp, we screened the allergens in it using the sera of shrimp-sensitive patients with atopic dermatitis and found only one protein, tropomyosin. This is a protein component, which form the muscle proteins in vertebrates and invertebrates, and is reported as a common allergic protein in seafood as well as Cepharopoda, Mollusca, Crustacea. In the present study, we attempted to purify tropomyosin (Pen j 1) from Penaceus japonicus, and prepared the monoclonal and polyclonal antibodies raised against the purified tropomyosin We investigated hypoallergenicity during cooking process by means of a sandwich enzyme-linked immunosorbent assay (ELISA) system established using the monoclonal and polyclonal antibodies obtained. Most of tropomyosin was extracted in the boiling water, suggesting that boiling process in cooking is effective in hypoallergenicity of shrimp.Furthermore, we investigated the cloning of cDNA encoding the allergen to reveal information concerning its complete primary structure and allergenicity. The cDNA clone was cloned by means of 5'- and 3'-RACE method using mRNA prepared from fresh shrimp as a template and encoded a protein consist of 284 amino acids. Further, a various of recombinant peptides were expressed in E. coli to elucidate the epitopes, the binding region with IgE in patients' sera. The result of epitope mapping showed that the epitopes occurred and were divided into several segments over a very wide region on the polypeptide chain of tropomyosin.
最近,在日本,许多患者都患有因摄入虾而引起的过敏。从我国虾的消费量来看,虾是一种重要的动物蛋白食品。为了阐明虾的过敏性,我们用虾过敏的特应性皮炎患者的血清对虾中的过敏原进行了筛选,发现只有一种蛋白质,原肌球蛋白。这是一种蛋白质成分,形成脊椎动物和无脊椎动物的肌肉蛋白质,据报道,它是海鲜以及头足类、软体动物和甲壳类动物中常见的过敏蛋白。本研究试图从日本对虾中提纯原肌球蛋白(Pen j-1),并制备抗原肌球蛋白的单抗和多克隆抗体。利用所获得的单抗和多克隆抗体建立的夹心酶联免疫吸附试验(EL ISA)系统,对烹调过程中的低变应原进行了研究。大部分原肌球蛋白是在沸水中提取的,这表明煮熟过程对虾的低过敏性是有效的。此外,我们对编码过敏原的cDNA的克隆进行了研究,以揭示其完整的一级结构和过敏性。采用5‘-RACE和3’-RACE方法,以新鲜对虾为模板,克隆了一个编码284个氨基酸的蛋白质。此外,在大肠杆菌中表达了一系列重组多肽,以确定患者血清中与IgE结合的表位。表位定位结果表明,这些表位在原肌球蛋白的多肽链上存在,并在很宽的区域内被分成几个片段。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yanashita H., Kimoto M., et al.: "Identification of a wheat allergen, Tri a Bd 36K, as a peroxidase"Biosci. Biotechnol. Biochem.. 66(11). 2487-2490 (2002)
Yanashita H.、Kimoto M. 等人:“作为过氧化物酶鉴定小麦过敏原 Tri a Bd 36K”Biosci。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KIMOTO Masumi其他文献

KIMOTO Masumi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KIMOTO Masumi', 18)}}的其他基金

Searching for neurodegenerative disease-related factors in the metabolic systems of ADMA-containing protein and the elucidation of the functional mechanism
寻找ADMA蛋白代谢系统中神经退行性疾病相关因子并阐明其功能机制
  • 批准号:
    23590683
  • 财政年份:
    2011
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Metabolism of ADMA, a novel risk factor of cardiovascular diseases and its pathophysiological role
心血管疾病新危险因素ADMA的代谢及其病理生理作用
  • 批准号:
    20590582
  • 财政年份:
    2008
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of a novel assay system of asymmetric dimethylarginine (ADMA), a risk factor for atherosclerosis.
开发一种新型的不对称二甲基精氨酸 (ADMA) 检测系统,ADMA 是动脉粥样硬化的危险因素。
  • 批准号:
    15590494
  • 财政年份:
    2003
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Screening of food allergy-causing factors and study on wheat allergy.
食物过敏因素筛查及小麦过敏研究.
  • 批准号:
    11680138
  • 财政年份:
    1999
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

PHASE 1 TRIAL FOR A THERAPEUTIC MONOCLONAL ANTIBODY FOR CHIKUNGUNYA VIRUS
基孔肯雅病毒治疗性单克隆抗体的第一阶段试验
  • 批准号:
    10892414
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
Base Title: PREVENT Preclinical Pharmacology and ToxicologyTask Order Title: Nicotine Reduction Therapy Using the Human Monoclonal Antibody ATI-1013
基本标题:预防临床前药理学和毒理学任务订单标题:使用人单克隆抗体 ATI-1013 进行尼古丁减少治疗
  • 批准号:
    10932479
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
Monoclonal Antibody Cocktail for Treatment of Marburg Virus Disease
用于治疗马尔堡病毒病的单克隆抗体混合物
  • 批准号:
    10761372
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
Targeting a ectonucleotidase in the heart with a monoclonal antibody to prevent post-infarct heart failure
用单克隆抗体靶向心脏中的核酸外切酶以预防梗死后心力衰竭
  • 批准号:
    10711469
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
Monoclonal Antibody to Combat Pseudomonas Aeruginosa
对抗铜绿假单胞菌的单克隆抗体
  • 批准号:
    10674274
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
Epitope-directed monoclonal antibody production for mosquito immune cells (for malaria)
针对蚊子免疫细胞(针对疟疾)的表位定向单克隆抗体生产
  • 批准号:
    10933280
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
On-cell screening of mouse hybridomas for improved monoclonal antibody discovery
小鼠杂交瘤的细胞筛选以改进单克隆抗体的发现
  • 批准号:
    10696698
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
Assessment of self-association of monoclonal antibody molecules by analysis of the protein layer detected at the proximity of a solid surface
通过分析在固体表面附近检测到的蛋白质层来评估单克隆抗体分子的自缔合
  • 批准号:
    10726173
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
STTR Phase I: Developing antifouling viral clearance membranes to enable efficient monoclonal antibody (mAb) processing
STTR 第一阶段:开发防污病毒清除膜以实现高效的单克隆抗体 (mAb) 处理
  • 批准号:
    2212947
  • 财政年份:
    2022
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Standard Grant
Development of transportable scFV monoclonal antibody into nucleus
可转运的scFV单克隆抗体进入细胞核的开发
  • 批准号:
    22K19387
  • 财政年份:
    2022
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了